Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Chella

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Four-modality therapy in malignant pleural mesothelioma: a phase II studyMarco Lucchi, Antonio Chella, Franca Melfi, et al.
Clinical Lung Cancer|June 28, 2006
Second-line chemotherapy with a modified schedule of docetaxel in elderly patients with advanced-stage non-small-cell lung cancerCarmelo Tibaldi, Ilaria Bernardini, Antonio Chella, et al.
Cancers|June 12, 2026
Pulmonary Embolism in Patients with Lung Cancer: Incidence and Performance of Prognostic MarkersFrancesco Tannura, Andrea Sbrana, Antonio Chella, et al.
Future Oncology (London, England)|May 6, 2024
Dabrafenib-trametinib in BRAF V600-mutated non-small-cell lung cancer: a single center real world experienceAndrea Sbrana, Sabrina Cappelli, Iacopo Petrini, et al.
Cancers|December 9, 2023
Validation of a Gene Expression Approach for the Cytological Diagnosis of Epithelioid and Biphasic Pleural Mesothelioma on a Consecutive SeriesRossella Bruno, Anello Marcello Poma, Greta Alì, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 26, 2006
A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesotheliomaMarco Lucchi, Antonio Chella, Franca Melfi, et al.
Molecular Medicine Reports|July 20, 2016
Aberrant expression of anaplastic lymphoma kinase in lung adenocarcinoma: Analysis of circulating free tumor RNA using one-step reverse transcription-polymerase chain reactionRossella Bruno, Mirella Giordano, Riccardo Giannini, et al.
Interactive Cardiovascular and Thoracic Surgery|January 8, 2010
Multimodality treatment of malignant pleural mesothelioma with or without immunotherapy: does it change anything?Marco Lucchi, Alessandro Picchi, Greta Alí, et al.
International Journal of Molecular Sciences|November 13, 2025
Prevalence of Histological Transformation in First-Line Osimertinib Non-Small Cell Lung Cancers: Case Series and Literature ReviewRebecca Sparavelli, Rossella Bruno, Alessandra Celi, et al.
Frontiers in Human Neuroscience|March 17, 2017
Reaching and Grasping a Glass of Water by Locked-In ALS Patients through a BCI-Controlled Humanoid RobotRossella Spataro, Antonio Chella, Brendan Allison, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Four-modality therapy in malignant pleural mesothelioma: a phase II studyMarco Lucchi, Antonio Chella, Franca Melfi, et al.
Clinical Lung Cancer|June 28, 2006
Second-line chemotherapy with a modified schedule of docetaxel in elderly patients with advanced-stage non-small-cell lung cancerCarmelo Tibaldi, Ilaria Bernardini, Antonio Chella, et al.
Cancers|June 12, 2026
Pulmonary Embolism in Patients with Lung Cancer: Incidence and Performance of Prognostic MarkersFrancesco Tannura, Andrea Sbrana, Antonio Chella, et al.
Future Oncology (London, England)|May 6, 2024
Dabrafenib-trametinib in BRAF V600-mutated non-small-cell lung cancer: a single center real world experienceAndrea Sbrana, Sabrina Cappelli, Iacopo Petrini, et al.
Cancers|December 9, 2023
Validation of a Gene Expression Approach for the Cytological Diagnosis of Epithelioid and Biphasic Pleural Mesothelioma on a Consecutive SeriesRossella Bruno, Anello Marcello Poma, Greta Alì, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 26, 2006
A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesotheliomaMarco Lucchi, Antonio Chella, Franca Melfi, et al.
Molecular Medicine Reports|July 20, 2016
Aberrant expression of anaplastic lymphoma kinase in lung adenocarcinoma: Analysis of circulating free tumor RNA using one-step reverse transcription-polymerase chain reactionRossella Bruno, Mirella Giordano, Riccardo Giannini, et al.
Interactive Cardiovascular and Thoracic Surgery|January 8, 2010
Multimodality treatment of malignant pleural mesothelioma with or without immunotherapy: does it change anything?Marco Lucchi, Alessandro Picchi, Greta Alí, et al.
International Journal of Molecular Sciences|November 13, 2025
Prevalence of Histological Transformation in First-Line Osimertinib Non-Small Cell Lung Cancers: Case Series and Literature ReviewRebecca Sparavelli, Rossella Bruno, Alessandra Celi, et al.
Frontiers in Human Neuroscience|March 17, 2017
Reaching and Grasping a Glass of Water by Locked-In ALS Patients through a BCI-Controlled Humanoid RobotRossella Spataro, Antonio Chella, Brendan Allison, et al.
Pageof 12